Abnormal T cells
in mycosis fungoides
Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to aggressive cancers). These cancers are often very responsive to treatments like chemotherapy, radiation, and immunotherapy. However, the early stages are less responsive, so the "Watch and Wait" method of treatment may be employed.
Radioimmunotherapy is also beginning to become a mainstream treatment with promising results. The Zevalin regimen has been approved for certain types of NHL.
The following are some of the cancers classified as indolent lymphoma: